Biom Therapeutics
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Biom Therapeutics operates in Healthcare & Life Sciences and is based in Sarasota, Florida. It was founded in 2020.
Biom Therapeutics is a biopharmaceutical company that develops novel therapies for rare neurological diseases, including Angelman syndrome and epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biom Therapeutics Comparables
Compare Biom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avata Biosciences | 83% | |
| Argent Biopharma Ltd | 82% | |
| MavriX Bio | 80% |
For institutional investors. Book with your work email.
Biom Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 526% MoM, from 129 to 808.
- May 2, 2025
Monthly visitors grew 121% MoM, reaching 976.
For institutional investors. Book with your work email.
Biom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biom Therapeutics's valuation, stock price, and market status.
Is Biom Therapeutics a public or private company?
Biom Therapeutics is a private company.
What is the current stock price of Biom Therapeutics?
Biom Therapeutics is a private company, so its shares have no public market price. Caplight tracks Biom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biom Therapeutics worth (valuation)?
Valuation information for Biom Therapeutics is not publicly available.
Can I buy Biom Therapeutics stock?
Biom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biom Therapeutics's last funding round?
Funding round information for Biom Therapeutics is not publicly available.
Who are the main investors in Biom Therapeutics?
Investor information for Biom Therapeutics is not publicly disclosed.
Will Biom Therapeutics IPO soon?
No public IPO plans have been announced for Biom Therapeutics.
How can I track Biom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Biom Therapeutics's shares on secondary markets.